Cancer– tag –
-
Frontier of Therapy Series: “Training” Immunity to Fight Cancer — CAR-T at a Glance (From Beginner to Expert) | B2: Toxicity Management, Site Operations & Long-Term Safety (Including Regulatory Logic) [Expert]
Prefer the beginner overview first?→ A0: What is CAR-T therapy? The big picture + index→ A2: CAR-T side effects without panic (what happens, what to monitor) “CAR-T Toxicity Management: Timeline × Actions × Follow-Up”Left: Day 0–14 (CRS/... -
Frontier of Therapy Series: “Training” Immunity to Fight Cancer — CAR-T at a Glance (From Beginner to Expert) | A2: CAR-T Side Effects Without Panic — What Can Happen & What to Monitor [Beginner]
New here? Start with the basics and where CAR-T is used today.→ A0: What Is CAR-T Therapy? The Big Picture + Series Index→ A1: Where CAR-T Is Used Today — Blood Cancers First Want the deep dive (B2)? We will cover severity grading concep... -
Frontier of Therapy Series: “Training” Immunity to Fight Cancer — CAR-T at a Glance (From Beginner to Expert) | A1: Where CAR-T Is Used Today — The Big Picture (Blood Cancers First) [Beginner]
New here? If you haven’t read the introduction, it will make this post much easier to follow.→ A0: What Is CAR-T Therapy? The Big Picture + Series Index Want the deep dive? The expert post (B1) will organize FDA-approved CAR-T products b... -
Frontier of Therapy Series: “Training” Immunity to Fight Cancer — CAR-T at a Glance (From Beginner to Expert) | A0: What Is CAR-T Therapy? The Big Picture, in Plain Language [Beginner]
How to use this series (two-layer linkage: Beginner → Expert) This series explains CAR-T therapy in a stepwise way so that readers who are new to the term can first grasp the big picture (Layer A), and then move to the expert layer (Laye... -
Oncology Drug Approval News Flash FDA approves teclistamab (Tecvayli) plus daratumumab hyaluronidase-fihj for relapsed/refractory multiple myeloma (and converts Tecvayli monotherapy from accelerated to traditional approval)
On March 5, 2026, the U.S. FDA approved teclistamab (Tecvayli), a BCMA×CD3 bispecific antibody, in combination with daratumumab hyaluronidase-fihj for adults with relapsed or refractory multiple myeloma (RRMM) who have received at least ... -
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 9: Childhood Cancers—The Big Picture and Where Families Can Ask First
“My child seems unusually tired.” “The fever keeps coming back.” “Bruises appear more easily.” Childhood cancers are uncommon, but once the thought appears, family anxiety can escalate fast. This article offers a calm, plain-language ove... -
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 8: Brain Tumors—When Headaches or Seizures Should Be Evaluated
“My headaches are getting worse.” “I had my first seizure.” “I feel my speech is off.” Brain tumors are emotionally charged, and the fear can escalate quickly. This article offers a calm, plain-language overview of how symptoms are commo... -
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 7: Ovarian Cancer—When Symptoms Are Vague, What Should You Check First?
“I’m constantly bloated.” “I feel full quickly.” “I’m going to the bathroom more often.” Ovarian cancer is a topic where uncertainty can quickly fuel anxiety, because early symptoms may be subtle or non-specific. This article offers a ca... -
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 6: Pancreatic Cancer—Why It’s Hard to Detect, and How Testing & Treatment Fit Together
“Pancreatic cancer is hard to detect.” “Symptoms are vague.” That uncertainty often fuels anxiety and a deep search spiral. This article provides a calm, plain-language overview of why early symptoms can be subtle, what symptoms may matt... -
Oncology Drug Approval News Flash: Zongertinib receives accelerated FDA approval for unresectable or metastatic HER2 TKD–mutated non-squamous non-small cell lung cancer in systemic therapy–naïve adults
FDA approval summary On February 26, 2026, the U.S. Food and Drug Administration (FDA) granted accelerated approval to the kinase inhibitor zongertinib (Hernexeos, Boehringer Ingelheim) for an expanded indication in adult patients with u... -
Oncology Drug Approval News Flash: Encorafenib plus cetuximab and fluorouracil-based chemotherapy receives traditional FDA approval for BRAF V600E–mutated metastatic colorectal cancer
FDA approval summary On February 24, 2026, the U.S. Food and Drug Administration (FDA) granted traditional approval to encorafenib (Braftovi, Array BioPharma Inc., a subsidiary of Pfizer Inc.) in combination with cetuximab and fluorourac... -
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 5: Prostate Cancer—Worried About Your PSA? A Calm Guide to Next Tests and Treatment Choices
“My PSA is high.” “My PSA keeps creeping up.” “They told me to repeat the test.” Prostate cancer often starts with a number, which can easily amplify worry. This article offers a calm, plain-language overview of what PSA can and cannot t... -
New Series Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 3: Worried About Stomach Cancer? Understanding H. pylori, Endoscopy, and Follow-up Calmly
“My stomach feels uncomfortable.” “I’ve had indigestion for weeks.” “My screening result says I need follow-up.” “I tested positive for H. pylori.” Stomach cancer searches can quickly become overwhelming. This article offers a calm, plai... -
New Series: Untangling Cancer Worries: Organ-by-Organ Basics at a Glance — Episode 4: Breast Cancer—What to Know First After Noticing a Lump (The Testing Pathway)
“Is this a lump?” “Why does this side look different?” “There’s nipple discharge.” Breast cancer searches can quickly become overwhelming. This article is a calm, plain-language overview of the next steps: when to seek care, the typical ... -
New Series Episode 2: If Colorectal Cancer Is on Your Mind—A Calm, Gentle Overview of Symptoms, Tests, Staging, and Treatment | Untangling Cancer Worries: Organ-by-Organ Basics at a Glance
“I noticed blood in my stool.” “My bowel habits have changed.” “My screening stool test came back positive.” Once you start searching, the amount of information can feel overwhelming—and anxiety can grow. This article helps you organize ... -
New Series 1: Lung Cancer—A Calm Overview Before You Jump to Conclusions (Cough, Shortness of Breath, Tests, Staging) | Untangling Cancer Worries: Organ-by-Organ Basics at a Glance
“My cough won’t go away.” “I get short of breath.” “My health check X-ray showed a shadow.” Once you start searching, it’s easy to get overwhelmed and more anxious. This article is a calm, plain-language “map” of lung cancer basics—sympt... -
Series: Untangling Cancer Worries — Your First GuidePart 8: Lung Cancer Basics—A Calm Map of Tests, Staging, and Treatment Flow (With When-to-Seek-Care Signs)
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. “My cough won’t go away.” “I’m more short of b... -
Series: Untangling Cancer Worries — Your First GuidePart 7: How to Read “Breakthrough Treatment” News Without Panic—Focus Only on What Matters in Real Life
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. Headlines like “breakthrough cancer drug,” “a ... -
Series: Untangling Cancer Worries — Your First GuidePart 6: What Is a Rare Cancer? How to Search When Information Is Limited—and What to Ask Clinicians
Series: Untangling Cancer Worries — Your First Guide Even without medical knowledge, this series helps you calmly sort out what to check right now—for yourself or for someone you care about. When someone says “It’s a rare cancer,” the fe... -
Oncology Drug Approval News Flash: Optune Pax, a low electric field tumor treating fields device, approved with gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer
FDA approval summary On February 11, 2026, the U.S. Food and Drug Administration (FDA) approved a low electric field generator device, Optune Pax (Novocure), in combination with gemcitabine and nab-paclitaxel for the treatment of adult p...
